Page 43 - Read Online

Page 12 of 14 Afyouni et al. Hepatoma Res 2023;9:28 https://dx.doi.org/10.20517/2394-5079.2023.29

resection. Liver Int 2021;41:837-50. DOI
41. Li MD, Lu XZ, Liu JF, et al. Preoperative survival prediction in intrahepatic cholangiocarcinoma using an ultrasound-based
radiographic-radiomics signature. J Ultrasound Med 2022;41:1483-95. DOI
42. Hao X, Liu B, Hu X, et al. A radiomics-based approach for predicting early recurrence in intrahepatic cholangiocarcinoma after
surgical resection: a multicenter study. Annu Int Conf IEEE Eng Med Biol Soc 2021;2021:3659-62. DOI
43. Yang Y, Zou X, Zhou W, et al. Multiparametric MRI-based radiomic signature for preoperative evaluation of overall survival in
intrahepatic cholangiocarcinoma after partial hepatectomy. J Magn Reson Imaging 2022;56:739-51. DOI
44. Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009;16:14-
22. DOI
45. Jiang W, Zeng ZC, Tang ZY, et al. A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the
Fudan score. Ann Oncol 2011;22:1644-52. DOI
46. Ma X, Liu L, Fang J, et al. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma. Cancer Imaging
2020;20:40. DOI PubMed PMC
47. Tsukamoto M, Yamashita YI, Imai K, et al. Predictors of cure of intrahepatic cholangiocarcinoma after hepatic resection. Anticancer
Res 2017;37:6971-5. DOI
48. Lee J, Kim SH, Kang TW, Song KD, Choi D, Jang KT. Mass-forming intrahepatic cholangiocarcinoma: diffusion-weighted imaging
as a preoperative prognostic marker. Radiology 2016;281:119-28. DOI
49. Zhou Y, Wang X, Xu C, et al. Mass-forming intrahepatic cholangiocarcinoma: can diffusion-weighted imaging predict microvascular
invasion? J Magn Reson Imaging 2019;50:315-24. DOI PubMed
50. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of
prognostic factors and lymph node assessment. J Clin Oncol 2011;29:3140-5. DOI PubMed
51. Ali SM, Clark CJ, Mounajjed T, et al. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo
Clinic experience. HPB 2015;17:244-50. DOI PubMed PMC
52. Al-Adra DP, Gill RS, Axford SJ, Shi X, Kneteman N, Liau SS. Treatment of unresectable intrahepatic cholangiocarcinoma with
yttrium-90 radioembolization: a systematic review and pooled analysis. Eur J Surg Oncol 2015;41:120-7. DOI PubMed PMC
53. Chun YS, Pawlik TM, Vauthey JN. 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg
Oncol 2018;25:845-7. DOI PubMed
54. Zhang XF, Lv Y, Weiss M, et al. Should utilization of lymphadenectomy vary according to morphologic subtype of intrahepatic
cholangiocarcinoma? Ann Surg Oncol 2019;26:2242-50. DOI
55. Tsilimigras DI, Sahara K, Paredes AZ, et al. Predicting lymph node metastasis in intrahepatic cholangiocarcinoma. J Gastrointest Surg
2021;25:1156-63. DOI
56. Weber SM, Ribero D, O'Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus
statement. HPB 2015;17:669-80. DOI PubMed PMC
57. Songthamwat M, Chamadol N, Khuntikeo N, et al. Evaluating a preoperative protocol that includes magnetic resonance imaging for
lymph node metastasis in the cholangiocarcinoma screening and care program (CASCAP) in Thailand. World J Surg Oncol
2017;15:176. DOI PubMed PMC
58. Paño B, Sebastià C, Ripoll E, et al. Pathways of lymphatic spread in gynecologic malignancies. Radiographics 2015;35:916-45. DOI
59. Park HS, Lee JM, Choi JY, et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography
versus MDCT with direct cholangiography. AJR Am J Roentgenol 2008;190:396-405. DOI
60. Hänninen EL, Pech M, Jonas S, et al. Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor
localization and therapy planning in malignant hilar obstructions. Acta Radiol 2005;46:462-70. DOI
61. Park MS, Lee DK, Kim MJ, et al. Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct
carcinoma. J Comput Assist Tomogr 2006;30:362-7. DOI
62. Fábrega-Foster K, Ghasabeh MA, Pawlik TM, Kamel IR. Multimodality imaging of intrahepatic cholangiocarcinoma. Hepatobiliary
Surg Nutr 2017;6:67-78. DOI PubMed PMC
63. Zhou Y, Zhou G, Gao X, Xu C, Wang X, Xu P. Apparent diffusion coefficient value of mass-forming intrahepatic
cholangiocarcinoma: a potential imaging biomarker for prediction of lymph node metastasis. Abdom Radiol 2020;45:3109-18. DOI
64. Ji GW, Zhu FP, Zhang YD, et al. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic
cholangiocarcinoma. Eur Radiol 2019;29:3725-35. DOI
65. Meng ZW, Lin XQ, Zhu JH, Han SH, Chen YL. A nomogram to predict lymph node metastasis before resection in intrahepatic
cholangiocarcinoma. J Surg Res 2018;226:56-63. DOI PubMed
66. Annunziata S, Caldarella C, Pizzuto DA, et al. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography
in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis. Biomed Res Int 2014;2014:247693. DOI
PubMed PMC
67. Fowler KJ, Saad NE, Linehan D. Imaging approach to hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer.
Surg Oncol Clin N Am 2015;24:19-40. PubMed
68. Ma KW, Cheung TT, She WH, et al. Diagnostic and prognostic role of 18-FDG PET/CT in the management of resectable biliary tract
cancer. World J Surg 2018;42:823-34. DOI
18
69. Kirchner J, Sawicki LM, Deuschl C, et al. F-FDG PET/MR imaging in patients with suspected liver lesions: value of liver-specific